-
Ukraine, Russia, US start second day of war talks
-
Nepal's youth lead the charge in the upcoming election
-
Sony hikes forecasts even as PlayStation falters
-
Rijksmuseum puts the spotlight on Roman poet's epic
-
Trump fuels EU push to cut cord with US tech
-
Fearless talent: Five young players to watch at the T20 World Cup
-
India favourites as T20 World Cup to begin after chaotic build-up
-
Voter swings raise midterm alarm bells for Trump's Republicans
-
Australia dodges call for arrest of visiting Israel president
-
Countries using internet blackouts to boost censorship: Proton
-
Top US news anchor pleads with kidnappers for mom's life
-
Thailand's pilot PM on course to keep top job
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Family affair: Thailand waning dynasty still election kingmaker
-
Japan's first woman PM tipped for thumping election win
-
Stocks in retreat as traders reconsider tech investment
-
LA officials call for Olympic chief to resign over Epstein file emails
-
Ukraine, Russia, US to start second day of war talks
-
Fiji football legend returns home to captain first pro club
-
Trump attacks US electoral system with call to 'nationalize' voting
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
US households become increasingly strained in diverging economy
-
Four dead men: the cold case that engulfed a Colombian cycling star
-
Super Bowl stars stake claims for Olympic flag football
-
On a roll, Brazilian cinema seizes its moment
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Indigenous Brazilians protest Amazon river dredging for grain exports
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Last US-Russia nuclear treaty ends in 'grave moment' for world
-
Man City brush aside Newcastle to reach League Cup final
-
Guardiola wants permission for Guehi to play in League Cup final
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
'Bad Boy,' 'Little Pablo' and Mordisco: the men on a US-Colombia hitlist
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Dallas deals Davis to Wizards in blockbuster NBA trade: report
-
Iran-US talks back on, as Trump warns supreme leader
-
Lens cruise into French Cup quarters, Endrick sends Lyon through
-
No.1 Scheffler excited for Koepka return from LIV Golf
-
Curling quietly kicks off sports programme at 2026 Winter Olympics
-
Undav pokes Stuttgart past Kiel into German Cup semis
-
Germany goalkeeper Ter Stegen to undergo surgery
-
Bezos-led Washington Post announces 'painful' job cuts
-
Iran says US talks are on, as Trump warns supreme leader
-
Gaza health officials say strikes kill 24 after Israel says officer wounded
-
Empress's crown dropped in Louvre heist to be fully restored: museum
-
UK PM says Mandelson 'lied' about Epstein relations
-
Shai to miss NBA All-Star Game with abdominal strain
-
Trump suggests 'softer touch' needed on immigration
Emigrate or waste away: dilemma for Venezuela multiple sclerosis patients
For Venezuelan Jaimar Tuarez, 22, being diagnosed with multiple sclerosis felt like a death sentence in a country unable to provide the drugs she needs to keep her ever-worsening symptoms at bay.
With no means of paying for private treatment or tests, including a spinal tap that costs $800, the psychology student has launched a crowd-funding campaign on GoFundMe that she hopes will allow her to travel abroad in search of medical help.
"For many people the only option is to emigrate," Tuarez, who was diagnosed in 2022, told AFP at her apartment in Charallave, a city some 50 kilometers (31 miles) from Caracas.
"I have to get out of here..." she said through tears. "What will happen with my next relapse? Will I lose the ability to speak? I am 22 years old... what will happen to all my dreams, my plans?"
The plight of Tuarez and an estimated 2,000 other Venezuelans with MS -- a potentially disabling disease of the central nervous system -- underlines the difficulties facing people in need of chronic medication in cash-strapped Venezuela.
There is no cure, but drugs can alleviate MS symptoms.
According to the Inter-American Commission on Human Rights (IAHCR), Venezuela's IVSS social welfare institute stopped providing prescription MS medication years ago.
Venezuela is in the grips of an unprecedented economic crisis, with its once-thriving oil industry all but collapsed and GDP shrinking by 80 percent in eight years of recession until 2022.
Millions have fled in search of a better life elsewhere, many seeking a path to the United States.
- 'We are adrift -
Tuarez has weakened to the point where she can barely stand, forcing her to abandon her psychology studies and quit her job as an online editor that had helped augment the family income.
Now Tuarez and her mother, a stroke survivor, both depend on the meager income of her 72-year-old grandmother, who works at a beauty salon in the capital.
Andres Marcano, a 53-year-old translator diagnosed with MS two decades ago, told AFP his mobility has drastically deteriorated in the last five years after he stopped receiving state-funded medication.
"I find it difficult to speak. I don't walk. I am unable to stand and therefore I move around in a wheelchair," he told AFP via WhatsApp.
The situation "is serious, we are adrift," said another MS sufferer, Maria Eugenia Monagas, 57, who pays privately for treatment thanks to the income of her husband and two children, one of them abroad.
"Many are disabled, or dead, due to a lack of medicines," she said.
The government of President Nicolas Maduro blames the state's failure on US sanctions. But others point to graft allegations against officials from the health ministry and the IVSS in a country with a long history of corruption and mismanagement, according to international observers.
- No options -
Tuarez said her last relapse left her temporarily unable to speak, walk or eat independently.
She was prescribed steroids to ease the symptoms, but could not get any through the IVSS.
In the private sector, the medicines she needs cost as much as $30,000 per year.
Tuarez said she spent Christmas Eve sending out emails to aid organizations in different countries, seeking help to leave the country with her mother, who needs care and cannot be left behind.
So far, she has collected $600 out of her objective of $10,000.
Tuarez is overwhelmed at the thought of leaving behind her family, a beloved dog and two cats, but fears her life is in danger if she does not.
"I wish there were other options, to make a career and live my life (in Venezuela), but there are none," Tuarez said.
Q.Najjar--SF-PST